Patents by Inventor Olivier Petrault

Olivier Petrault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
    Patent number: 8252748
    Abstract: The invention relates to a peptide derived from neurotensin receptor 3 (NTSR3), and to the use thereof in the treatment of psychiatric diseases. The present invention particularly relates to the use of this peptide for producing a drug, such as an antidepressant. The peptide of the invention is characterized in that the sequence thereof is the attached SEQ ID No. 2. The present invention can be used in the fields of the pharmaceutical industry and particularly in the field of drug development for treating psychiatric diseases. The present invention can also be used in the development of a novel antidepressant. It can also be used for example, in the treatment of pain and inflammations.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: August 28, 2012
    Assignees: Centre National de la Recherche Scientifique—CNRS, Universite de Nice Sophia Antipolis
    Inventors: Jean Mazella, Olivier Petrault, Marc Borsotto, Catherine Heurteaux, Catherine Widmann
  • PEPTIDE DERIVED FROM NEUROTESIN RECEPTOR 3 AND USE THEREOF IN THE TREATMENT OF PSYCHIATRIC DISEASES
    Publication number: 20110237515
    Abstract: The invention relates to a peptide derived from neurotensin receptor 3 (NTSR3), and to the use thereof in the treatment of psychiatric diseases. The present invention particularly relates to the use of this peptide for producing a drug, such as an antidepressant. The peptide of the invention is characterized in that the sequence thereof is the attached SEQ ID No. 2. The present invention can be used in the fields of the pharmaceutical industry and particularly in the field of drug development for treating psychiatric diseases. The present invention can also be used in the development of a novel antidepressant. It can also be used for example, in the treatment of pain and inflammations.
    Type: Application
    Filed: December 18, 2008
    Publication date: September 29, 2011
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE- CNRS-, UNIVERSITE DE NICE SOPHIA ANTIPOLIS
    Inventors: Jean Mazella, Olivier Petrault, Marc Borsotto, Catherine Heurteaux, Catherine Widmann